
Atomgrid Targets Global 'China-plus-one' Shift With Massive R&D Expansion in Bengaluru
Atomgrid, a full-stack speciality chemicals platform, has strategically inaugurated a new research and development centre in Bengaluru. The move positions the company to capitalize on the growing global trend seeking alternative supply chains outside of China. This facility marks a major commitment to strengthening India's role in the international chemicals market.Tapping the 'China-plus-one' Chemical Opportunity
The launch of the Bengaluru R&D centre is a direct response to global customers actively diversifying their supply base. Global demand is accelerating for alternative sourcing strategies, often termed the 'China-plus-one' shift.According to Siddharth Gupta, co-founder of Atomgrid, this expansion underscores that India is at a pivotal inflection point in speciality chemicals. He emphasized that modern global clients require more than just basic sourcing; they seek comprehensive solution providers.
Enhancing Proprietary Chemical Development Capabilities
The core focus of the new centre will be the development of proprietary processes. This includes creating patented formulations and mastering the active ingredients required for global markets.The facility is designed to produce high-purity, cost-efficient products. Its technical expertise covers process chemistry and quality systems appropriate for both regulated and non-regulated markets. This holistic approach is central to the company's offering.
Scaling Operations and Future Growth Trajectory
The centre is currently operational with 15 scientists and researchers. Atomgrid has robust plans to significantly scale its human capital, intending to expand its team to 25 personnel over the next 12 months.The capabilities housed within the facility are extensive, spanning critical functions like route scouting, process development, and technology transfer for commercial-scale manufacturing.
Funding Fuels Global Footprint Expansion
This strategic R&D expansion follows the successful closure of a USD 7 million pre-Series A fundraise. The capital secured is earmarked to significantly strengthen the company's global footprint and enhance its advanced research and development capabilities.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.